Intermune Inc (ITMN) Financial Statements (2025 and earlier)

Company Profile

Business Address 3280 BAYSHORE
BRISBANE, CA 94005
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:606,427387,007337,244500800 
Cash and cash equivalent399,562191,433117,285157,525168,984 
Short-term investments206,865195,574219,959229,206272,955 
Other undisclosed cash, cash equivalents, and short-term investments    (386,231)(441,139) 
Receivables25,64021,43616,55411,6607,062 
Inventory, net of allowances, customer advances and progress billings  10,4239,82910,191
Inventory   10,4239,82910,191 
Prepaid expense and other current assets6,521 
Other undisclosed current assets23,44020,7259,384394,426441,139 
Total current assets:655,507429,168373,605416,415465,713 
Noncurrent Assets
Property, plant and equipment4,6244,7064,6184,0494,355 
Intangible assets, net (including goodwill)17,00017,250
Intangible assets, net (excluding goodwill)17,00017,250    
Restricted cash and investments3,7314,5314,8074,6774,831 
Other noncurrent assets10,35711,50912,18312,663 
Prepaid expense and other noncurrent assets13,615 
Other undisclosed noncurrent assets(3,731)(4,531)12,69313,07313,169 
Total noncurrent assets:31,98133,46534,30134,46235,970 
TOTAL ASSETS:687,488462,633407,906450,877501,683 
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities59,49663,04821,95521,20919,394 
Employee-related liabilities12,56517,14813,47910,2637,443 
Accounts payable14,13116,7788,47610,94611,951 
Accrued liabilities32,80029,122    
Debt18,360     
Other undisclosed current liabilities   27,05127,44328,520 
Total current liabilities:77,85663,04849,00648,65247,914 
Noncurrent Liabilities
Long-term debt and lease obligation248,271265,102263,611262,156260,808 
Long-term debt, excluding current maturities248,271265,102263,611262,156260,808 
Liabilities, other than long-term debt178200221242249 
Other liabilities178200221242249 
Total noncurrent liabilities:248,449265,302263,832262,398261,057 
Total liabilities:326,305328,350312,838311,050308,971 
Equity
Equity, attributable to parent361,183134,28395,068139,827164,583 
Common stock9990828282 
Additional paid in capital1,731,5391,450,9371,354,9051,350,7361,312,425 
Accumulated other comprehensive income (loss)710774698(296)(99) 
Accumulated deficit(1,371,165)(1,317,518)(1,260,617)(1,210,695)(1,147,825) 
Total equity:361,183134,28395,068139,827164,583 
Other undisclosed liabilities and equity     28,129 
TOTAL LIABILITIES AND EQUITY:687,488462,633407,906450,877501,683 

Income Statement (P&L) ($ in thousands)

6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
Revenues30,27425,69119,71814,40010,530 
Revenue, net  25,69119,71814,40010,530 
Cost of revenue
(Cost of Product and Service Sold)
(3,365)(3,328)(2,759)(1,943)(2,376) 
Gross profit:26,90922,36316,95912,4578,154 
Operating expenses(76,378)(76,366)(62,535)(65,004)(55,982) 
Other undisclosed operating income  1,000 200130 
Operating loss:(49,469)(53,003)(45,576)(52,347)(47,698) 
Nonoperating income (expense)(199)(583)(758)(459)617 
Investment income, nonoperating1038293115137 
Other nonoperating income (expense)(302)(665)(851)(574)480 
Interest and debt expense(3,860)(3,818)(3,667)(3,634)(11,383) 
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes    (6,336)8,758 
Loss from continuing operations before income taxes:(53,528)(57,404)(50,001)(62,776)(49,706) 
Income tax expense (benefit)(490)231(241)(481)(399) 
Loss from continuing operations:(54,018)(57,173)(50,242)(63,257)(50,105) 
Loss before gain (loss) on sale of properties:(53,647)(56,901)(49,922)(62,870)(49,875) 
Income from discontinued operations371272320387230 
Net loss available to common stockholders, diluted:(53,647)(56,901)(49,922)(62,870)(49,875) 

Comprehensive Income ($ in thousands)

6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
Net loss:(53,647)(56,901)(49,922)(62,870)(49,875) 
Other comprehensive income (loss)(64)76994(197)(600) 
Comprehensive loss, net of tax, attributable to parent:(53,711)(56,825)(48,928)(63,067)(50,475) 

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: